Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.45
EXAC's Cash to Debt is ranked higher than
55% of the 397 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. EXAC: 0.45 )
EXAC' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.45

Equity to Asset 0.78
EXAC's Equity to Asset is ranked higher than
84% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. EXAC: 0.78 )
EXAC' s 10-Year Equity to Asset Range
Min: 0.39   Max: 0.88
Current: 0.78

0.39
0.88
Interest Coverage 19.57
EXAC's Interest Coverage is ranked higher than
56% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 155.63 vs. EXAC: 19.57 )
EXAC' s 10-Year Interest Coverage Range
Min: 4.67   Max: 9999.99
Current: 19.57

4.67
9999.99
F-Score: 8
Z-Score: 5.95
M-Score: -2.81
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 10.26
EXAC's Operating margin (%) is ranked higher than
81% of the 387 Companies
in the Global Medical Devices industry.

( Industry Median: 6.58 vs. EXAC: 10.26 )
EXAC' s 10-Year Operating margin (%) Range
Min: 6.73   Max: 20.53
Current: 10.26

6.73
20.53
Net-margin (%) 6.61
EXAC's Net-margin (%) is ranked higher than
79% of the 387 Companies
in the Global Medical Devices industry.

( Industry Median: 5.13 vs. EXAC: 6.61 )
EXAC' s 10-Year Net-margin (%) Range
Min: 4.3   Max: 11.59
Current: 6.61

4.3
11.59
ROE (%) 7.91
EXAC's ROE (%) is ranked higher than
77% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 5.61 vs. EXAC: 7.91 )
EXAC' s 10-Year ROE (%) Range
Min: 5.68   Max: 19.05
Current: 7.91

5.68
19.05
ROA (%) 6.16
EXAC's ROA (%) is ranked higher than
82% of the 397 Companies
in the Global Medical Devices industry.

( Industry Median: 3.34 vs. EXAC: 6.16 )
EXAC' s 10-Year ROA (%) Range
Min: 3.79   Max: 9.38
Current: 6.16

3.79
9.38
ROC (Joel Greenblatt) (%) 13.76
EXAC's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 396 Companies
in the Global Medical Devices industry.

( Industry Median: 11.81 vs. EXAC: 13.76 )
EXAC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.36   Max: 22.49
Current: 13.76

8.36
22.49
Revenue Growth (%) 6.00
EXAC's Revenue Growth (%) is ranked higher than
76% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. EXAC: 6.00 )
EXAC' s 10-Year Revenue Growth (%) Range
Min: 6   Max: 30.5
Current: 6

6
30.5
EBITDA Growth (%) 8.10
EXAC's EBITDA Growth (%) is ranked higher than
84% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: -2.10 vs. EXAC: 8.10 )
EXAC' s 10-Year EBITDA Growth (%) Range
Min: 2.4   Max: 38.1
Current: 8.1

2.4
38.1
EPS Growth (%) 11.90
EXAC's EPS Growth (%) is ranked higher than
83% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. EXAC: 11.90 )
EXAC' s 10-Year EPS Growth (%) Range
Min: -8.3   Max: 34.6
Current: 11.9

-8.3
34.6
» EXAC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

EXAC Guru Trades in Q3 2013

Jim Simons 24,200 sh (+32.97%)
Chuck Royce 1,007,895 sh (+0.49%)
Joel Greenblatt Sold Out
Mario Gabelli 673,835 sh (-2.26%)
» More
Q4 2013

EXAC Guru Trades in Q4 2013

Mario Gabelli 672,135 sh (-0.25%)
Chuck Royce 987,244 sh (-2.05%)
Jim Simons 23,000 sh (-4.96%)
» More
Q1 2014

EXAC Guru Trades in Q1 2014

Mario Gabelli 666,440 sh (-0.85%)
Chuck Royce 924,019 sh (-6.4%)
Jim Simons 17,800 sh (-22.61%)
» More
Q2 2014

EXAC Guru Trades in Q2 2014

Jim Simons 24,981 sh (+40.34%)
Mario Gabelli 675,440 sh (+1.35%)
Chuck Royce 848,119 sh (-8.21%)
» More
» Details

Insider Trades

Latest Guru Trades with EXAC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-09-30 Sold Out 0.01%$18.48 - $21.98 $ 24.2221%0
Joel Greenblatt 2013-06-30 New Buy0.01%$17.9 - $20.76 $ 24.2229%15150
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 20.90
EXAC's P/E(ttm) is ranked higher than
90% of the 419 Companies
in the Global Medical Devices industry.

( Industry Median: 64.90 vs. EXAC: 20.90 )
EXAC' s 10-Year P/E(ttm) Range
Min: 13.61   Max: 38.52
Current: 20.9

13.61
38.52
P/B 1.60
EXAC's P/B is ranked higher than
86% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. EXAC: 1.60 )
EXAC' s 10-Year P/B Range
Min: 1.11   Max: 4.67
Current: 1.6

1.11
4.67
P/S 1.40
EXAC's P/S is ranked higher than
84% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. EXAC: 1.40 )
EXAC' s 10-Year P/S Range
Min: 0.85   Max: 3.54
Current: 1.4

0.85
3.54
PFCF 15.70
EXAC's PFCF is ranked higher than
95% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 15.70 )
EXAC' s 10-Year PFCF Range
Min: 14.45   Max: 353.86
Current: 15.7

14.45
353.86
EV-to-EBIT 13.81
EXAC's EV-to-EBIT is ranked higher than
93% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 45.27 vs. EXAC: 13.81 )
EXAC' s 10-Year EV-to-EBIT Range
Min: 9.1   Max: 25.4
Current: 13.81

9.1
25.4
PEG 1.85
EXAC's PEG is ranked higher than
94% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 1.85 )
EXAC' s 10-Year PEG Range
Min: 1.18   Max: 4.5
Current: 1.85

1.18
4.5
Shiller P/E 26.60
EXAC's Shiller P/E is ranked higher than
91% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 26.60 )
EXAC' s 10-Year Shiller P/E Range
Min: 15.71   Max: 53.41
Current: 26.6

15.71
53.41
Current Ratio 4.43
EXAC's Current Ratio is ranked higher than
83% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. EXAC: 4.43 )
EXAC' s 10-Year Current Ratio Range
Min: 1.64   Max: 8.45
Current: 4.43

1.64
8.45
Quick Ratio 2.11
EXAC's Quick Ratio is ranked higher than
70% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 2.12 vs. EXAC: 2.11 )
EXAC' s 10-Year Quick Ratio Range
Min: 0.47   Max: 5.4
Current: 2.11

0.47
5.4

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 12.00
EXAC's Price/Net Current Asset Value is ranked higher than
88% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 12.00 )
EXAC' s 10-Year Price/Net Current Asset Value Range
Min: 3.38   Max: 119.95
Current: 12

3.38
119.95
Price/Tangible Book 1.80
EXAC's Price/Tangible Book is ranked higher than
90% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. EXAC: 1.80 )
EXAC' s 10-Year Price/Tangible Book Range
Min: 1.37   Max: 4.7
Current: 1.8

1.37
4.7
Price/DCF (Projected) 2.10
EXAC's Price/DCF (Projected) is ranked higher than
85% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 123.59 vs. EXAC: 2.10 )
EXAC' s 10-Year Price/DCF (Projected) Range
Min: 1.93   Max: 382.75
Current: 2.1

1.93
382.75
Price/Median PS Value 1.00
EXAC's Price/Median PS Value is ranked higher than
82% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 1.17 vs. EXAC: 1.00 )
EXAC' s 10-Year Price/Median PS Value Range
Min: 0.65   Max: 2.35
Current: 1

0.65
2.35
Price/Peter Lynch Fair Value 2.00
EXAC's Price/Peter Lynch Fair Value is ranked higher than
95% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 2.00 )
EXAC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.65   Max: 4.41
Current: 2

0.65
4.41
Price/Graham Number 1.30
EXAC's Price/Graham Number is ranked higher than
94% of the 420 Companies
in the Global Medical Devices industry.

( Industry Median: 7.56 vs. EXAC: 1.30 )
EXAC' s 10-Year Price/Graham Number Range
Min: 0.91   Max: 2.67
Current: 1.3

0.91
2.67
Earnings Yield (Greenblatt) 7.20
EXAC's Earnings Yield (Greenblatt) is ranked higher than
87% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. EXAC: 7.20 )
EXAC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 10.9
Current: 7.2

3.9
10.9
Forward Rate of Return (Yacktman) 9.50
EXAC's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.32 vs. EXAC: 9.50 )
EXAC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.6   Max: 16.3
Current: 9.5

3.6
16.3

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Exactech, Inc. was incorporated in Florida. The Company develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. It manufactures some components of its knee, extremity, and hip joint replacement systems at its facility in Gainesville, Florida, utilizing modern, highly automated computer aided manufacturing equipment. The company's cellular based manufacturing processes, which are organized in groups, or cells, are dedicated to specific product lines to minimize change-over and increase efficiency, and are designed to help it reduce the company's production cycle times while permitting flexibility to adjust quickly to changes in demand. To supplement its manufacturing of components, the company has formed strategic alliances with suppliers and business partners to externally manufacture some components. Additionally, it acquires and distributes other products and services through exclusive agreements, such as its agreement with Tecres (r) S.p.A, and non-exclusive agreements, such as with RTI Biologics, Inc. or RTI and Biomatlante SARL. In marketing its products, the company uses a combination of traditional targeted media marketing together with its main marketing focus, direct customer contact and service to orthopaedic surgeons. Products include: Knee Implants, Hip Implants, Biologics and Spine, Extremities.The Company markets its orthopaedic implant products in the United States through a network of independent sales agencies and direct sales representatives. Its competitors in the orthopaedic device market are DePuy, Inc., a division of Johnson and Johnson, Zimmer, Inc., a subsidiary of Zimmer Holdings, Inc., Stryker Howmedica Osteonics, a subsidiary of Stryker Corp., Smith and Nephew plc, and Biomet Orthopaedics, a subsidiary of Biomet, Inc. Healthcare is heavily regulated by the federal government and by state and local governments.
» More Articles for EXAC

Headlines

Articles On GuruFocus.com
What the Gurus Did This Week - Weekly Update on Guru Real Time Activity Jun 28 2013 
Mario Gabelli Ups His Holdings in EXAC, TWIN and LAYN Jun 28 2013 
comment on EXAC Oct 03 2011 
Exactech Inc. Reports Operating Results (10-K) Mar 16 2011 
Exactech Inc. Reports Operating Results (10-Q) Nov 09 2010 
Chuck Royce’s Top Predictable Companies: MEDNAX, Techne Corp., ITT Educational Services, Exactech May 17 2010 
Exactech Inc. Reports Operating Results (10-Q) May 05 2010 
Exactech Inc. (EXAC) CFO and Treasurer Joel C Phillips sells 2,497 Shares May 04 2010 
Exactech Inc. (EXAC) CEO and Chairman, 10% Owner R William Petty sells 20,000 Shares Dec 11 2009 
Exactech Inc. Reports Operating Results (10-Q) Nov 05 2009 

More From Other Websites
EXACTECH INC Financials Aug 15 2014
Exactech Announces First Implantation of New Alteon™ Tapered Wedge Femoral Stem Aug 13 2014
EXACTECH INC Files SEC form 10-Q, Quarterly Report Aug 06 2014
EXACTECH INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jul 28 2014
Exactech Q2 Revenue Up 6% to $63.9 Million. Net Income up 12% to $4.2 Million. Diluted EPS $0.30 vs.... Jul 28 2014
Exactech Schedules Second Quarter 2014 Earnings Release and Conference Call Jul 10 2014
Exactech Launches New Porous Technology for Total Knee Arthroplasty Jul 03 2014
Twenty ExactechGPS® Guided Personalized Surgery Abstracts Accepted into Five Leading Orthopaedic... Jun 11 2014
Exactech Announces First International Introduction of ExactechGPS® Guided Personalized Surgery at... Jun 04 2014
W. Andrew Krusen Elected to Exactech Board of Directors May 15 2014
EXACTECH INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 13 2014
EXACTECH INC Files SEC form 10-Q, Quarterly Report Apr 30 2014
Exactech's CEO Discusses Q1 2014 Results - Earnings Call Transcript Apr 22 2014
Will A Positive Earnings Report Help Exactech (EXAC) Stock? Apr 21 2014
EXACTECH INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 21 2014
Exactech Q1 Revenue Up 7% to $63.3 Million; Net Income up 9% to $4.2 Million; Diluted EPS $0.30 vs.... Apr 21 2014
Faruqi & Faruqi, LLP Launches An Investigation Against Exactech Inc. (EXAC) Potential Breaches Of... Apr 11 2014
Exactech Schedules First Quarter 2014 Earnings Release and Conference Call Apr 09 2014
Exactech To Conduct Intercontinental Masters Course in Shoulder Arthroplasty Apr 03 2014
EXACTECH INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 27 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK